GSK warns of declining vaccine sales in 2024 due to lower demand for respiratory syncytial virus vaccines
GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, sending its shares down 4 per cent in early trading.
ПОПУЛЯРНЫЕ ПОСТЫ
UK sets new climate target for 2035
Ноябрь 13, 2024
Children go back to school after Valencia floods
Ноябрь 13, 2024
Researchers document huge decline in African elephants
Ноябрь 13, 2024
Mission: Impossible 8 title revealed
Ноябрь 13, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ